Common Causes of Slight Elevation in Liver Enzymes
The most common causes of mild elevations in liver enzymes are nonalcoholic fatty liver disease (NAFLD) and alcohol-induced liver disease, followed by less common causes including drug-induced liver injury, viral hepatitis (B and C), and hereditary hemochromatosis. 1
Hepatocellular Pattern (Predominant ALT/AST Elevation)
Common Causes
- Nonalcoholic fatty liver disease (NAFLD) - Most common liver disease in developed countries with prevalence of 20-30% in general population, increasing to 70% with obesity and 90% with diabetes 1
- Alcohol-induced liver disease - AST:ALT ratio typically >2, compared to <1 in metabolic-related fatty liver 1
- Medication-related - Prescription drugs (including statins which can cause persistent transaminase elevations in 0.7% of patients), over-the-counter medications, and herbal supplements 2, 3
Less Common Causes
- Viral hepatitis - Acute or chronic hepatitis B, C, A, and E 1
- Hereditary hemochromatosis - Characterized by elevated ferritin and transferrin saturation >45% 1
- Autoimmune hepatitis - Often with positive autoantibodies and elevated IgG 1
Rare Causes
- Wilson disease - Copper metabolism disorder 1
- Alpha-1 antitrypsin deficiency - Genetic disorder affecting liver and lungs 1
Cholestatic Pattern (Predominant ALP/GGT Elevation)
- Biliary obstruction - Including choledocholithiasis, which can sometimes cause markedly elevated transaminases even without primary liver disease 4
- Primary biliary cholangitis - Characterized by positive anti-mitochondrial antibodies 1
- Primary sclerosing cholangitis - Often associated with inflammatory bowel disease 1
- Drug-induced cholestasis - Various medications can cause cholestatic pattern 1, 5
Non-Hepatic Causes of Elevated Liver Enzymes
- Muscle disorders - Can elevate AST (less specific for liver injury) 6, 7
- Thyroid disease - Both hypo- and hyperthyroidism can affect liver enzymes 6
- Hemolysis - Can cause elevated AST 1
- Strenuous exercise - Transient elevation, particularly of AST 1, 6
- Celiac disease - Can present with elevated transaminases 1
Initial Evaluation Approach
History and Risk Assessment
- Obtain detailed alcohol consumption history 6
- Complete medication review including prescription, over-the-counter, and supplements 6, 3
- Assess for metabolic syndrome components (obesity, diabetes, hypertension) 6
- Evaluate for symptoms of chronic liver disease (fatigue, jaundice, pruritus) 6
Laboratory Testing
- Complete liver panel (AST, ALT, alkaline phosphatase, bilirubin, albumin, prothrombin time) 6
- Viral hepatitis serologies (HBsAg, anti-HCV) 1, 6
- Consider autoimmune markers if suspected (ANA, ASMA, IgG) 1
- Thyroid function tests to rule out thyroid disorders 6
- Creatine kinase if muscle disorders suspected 6, 7
Imaging
- Abdominal ultrasound as first-line imaging test (sensitivity 84.8% and specificity 93.6% for moderate to severe hepatic steatosis) 1, 6
Important Considerations
- Normal ALT ranges differ by sex: 29-33 IU/L for males and 19-25 IU/L for females 6
- Up to 30% of mildly elevated transaminases may normalize spontaneously during follow-up 5
- The pattern of enzyme elevation can help guide diagnosis - hepatocellular (predominantly ALT/AST) versus cholestatic (predominantly ALP/GGT) 5, 7
- Patients with previous viral hepatitis should be screened for additional factors of liver damage even if asymptomatic or with normal liver tests 1
- Consider liver biopsy in cases where non-invasive testing is inconclusive, especially with persistent unexplained elevations 1
Management Approach
- For NAFLD: Implement lifestyle modifications including weight loss, exercise, and dietary changes 6
- For alcoholic liver disease: Recommend alcohol cessation and monitor transaminases 6
- For medication-induced injury: Discontinue suspected hepatotoxic medications when possible 6
- For viral hepatitis: Refer for specific management based on viral etiology 6
- For unexplained mild elevations: Repeat liver enzymes in 2-4 weeks 6
- Consider hepatology referral if transaminases remain elevated for ≥6 months or if there is evidence of synthetic dysfunction 6, 7